Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06916845 · ClinicalTrials.gov registry record · NA
Data Collection for CV-3E AI Software Development
A NA study of Colonic Polyps, sponsored by Capso Vision.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
- 4
- Study locations
NCT06916845: Completed NA study of Colonic Polyps, sponsored by Capso Vision.
NCT06916845 is a NA study of Colonic Polyps that has completed, run by Capso Vision. The registered enrollment target is 86 participants, below the 775-participant average among 6 other Colonic Polyps trials with a reported enrollment target (89% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06916845, a NA study of Colonic Polyps, has completed, sponsored by Capso Vision.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this clinical trial is to collect capsule images for the development of CADe software for use with the CapsoCam® Colon (CV-3E) in healthy volunteers who have been referred for colonoscopy. There will be no analysis performed as part of this protocol. Participants will * adhere to bowel prep instructions and dietary requirements * ingest pro-kinetic medication and CapsoCam® Colon (CV-3E) * adhere to booster regimen and dietary requirements until capsule passes * retrieve capsule with retrieval kit per instructions and mail back to sponsor * participate in follow-up phone call
Primary Outcome
No assessment will be done for this protocol. Videos will be collected for AI development for use in future study.
Conditions Studied
Interventions
- DEVICE Colon Capsule
Study Locations (4)
Florida
- Advanced Research Institute Inc - New Port Richey
- Advanced Gastroenterology Associates, LLC - Palm Harbor
Mississippi
- Digestive Diseases Center of Hattiesburg, LLC - Hattiesburg
Virginia
- Gastroenterology Consultants of Southwest Virginia - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2025-03-16 |
| Est. Completion | 2025-06-06 |
| Phase | NA |
What the finished NCT06916845 record still lists
NCT06916845 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 775-participant average among 6 other Colonic Polyps trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Colonic Polyps appearing as the primary indexed condition, and to 1 intervention - of which Colon Capsule is the first listed.
NCT06916845 reports a single indexed study location in Florida, Mississippi, Virginia.
Frequently Asked Questions
What is clinical trial NCT06916845 about?
NCT06916845 is a clinical study titled "Data Collection for CV-3E AI Software Development". The goal of this clinical trial is to collect capsule images for the development of CADe software for use with the CapsoCam® Colon (CV-3E) in healthy volunteers who have been referred for colonoscopy. There will be no analysis performed as part of this protocol. Participants will * adhere to bowel...
What is the current status of trial NCT06916845?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2025-03-16. Estimated completion is 2025-06-06.
What conditions does trial NCT06916845 study?
This clinical trial studies the following conditions: Colonic Polyps.
What interventions are being tested in trial NCT06916845?
The interventions under investigation include: Colon Capsule (DEVICE).
Who is sponsoring clinical trial NCT06916845?
This trial is sponsored by Capso Vision, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06916845 being conducted?
This trial has 4 study locations across Florida, Mississippi, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonic Polyps
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
RECRUITING · NA
-
Japanese National Computed Tomographic (CT) Colonography Trial
COMPLETED · NA
-
Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
COMPLETED · NA
-
Clinical Study of Real Time Colorectal Polyp Diagnosis During Colonoscopy - the VALID Colonoscopy Study
COMPLETED · NA
-
Improving Bowel Preparation for Colonoscopy With a Simple Educational Card
COMPLETED · NA
-
Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI